TrialPalliative medicine2012

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

Sam H Ahmedzai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.